193 related articles for article (PubMed ID: 20637805)
1. Detection and typing of low-risk human papillomavirus genotypes HPV 6, HPV 11, HPV 42, HPV 43 and HPV 44 by polymerase chain reaction and restriction fragment length polymorphism.
Maver PJ; Poljak M; Seme K; Kocjan BJ
J Virol Methods; 2010 Oct; 169(1):215-8. PubMed ID: 20637805
[TBL] [Abstract][Full Text] [Related]
2. Detection and differentiation of human papillomavirus genotypes HPV-6 and HPV-11 by FRET-based real-time PCR.
Kocjan BJ; Seme K; Poljak M
J Virol Methods; 2008 Nov; 153(2):245-9. PubMed ID: 18722474
[TBL] [Abstract][Full Text] [Related]
3. Simple and rapid human papillomavirus genotyping method by restriction fragment length polymorphism analysis with two restriction enzymes.
Chen L; Watanabe K; Haruyama T; Kobayashi N
J Med Virol; 2013 Jul; 85(7):1229-34. PubMed ID: 23918541
[TBL] [Abstract][Full Text] [Related]
4. Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm.
Nobre RJ; de Almeida LP; Martins TC
J Clin Virol; 2008 May; 42(1):13-21. PubMed ID: 18304866
[TBL] [Abstract][Full Text] [Related]
5. Universal ProbeLibrary based real-time PCR assay for detection and confirmation of human papillomavirus genotype 52 infections.
Kocjan BJ; Poljak M; Seme K
J Virol Methods; 2010 Feb; 163(2):492-4. PubMed ID: 19883693
[TBL] [Abstract][Full Text] [Related]
6. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
7. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR.
Lin CY; Chao A; Yang YC; Chou HH; Ho CM; Lin RW; Chang TC; Chiou JY; Chao FY; Wang KL; Chien TY; Hsueh S; Huang CC; Chen CJ; Lai CH
J Clin Virol; 2008 Aug; 42(4):361-7. PubMed ID: 18455959
[TBL] [Abstract][Full Text] [Related]
9. High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping.
Tanzi E; Bianchi S; Fasolo MM; Frati ER; Mazza F; Martinelli M; Colzani D; Beretta R; Zappa A; Orlando G
J Med Virol; 2013 Jan; 85(1):91-8. PubMed ID: 23097252
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric GP5+/6+ PCR and hybridization with fluorescence polarization assay of 15 human papillomavirus genotypes in clinical samples.
Ju Z; Yane G; Ding L; Guowu Y; Yanhai G; Yonglan L
J Clin Virol; 2009 Feb; 44(2):106-10. PubMed ID: 19144564
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
Harnish DG; Belland LM; Scheid EE; Rohan TE
Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
[TBL] [Abstract][Full Text] [Related]
12. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers.
Schmitt M; Dondog B; Waterboer T; Pawlita M
J Clin Microbiol; 2008 Mar; 46(3):1050-9. PubMed ID: 18199790
[TBL] [Abstract][Full Text] [Related]
13. A novel fluorescence polarization based assay for 14 human papillomavirus genotypes in clinical samples.
Zhang J; Chen Z; Gao Y; Jiang Y; Xia L; Guo Y; Yan X
J Virol Methods; 2006 Jun; 134(1-2):223-9. PubMed ID: 16488487
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of AMPLICOR HPV PCR and Linear Array assays on SurePath liquid-based Pap samples for the detection of high-risk HPV genotypes.
Chernesky M; Jang D; Portillo E; Smieja M; Chong S; Buracond S; Klingel M; El Sebai R; Kapala J; Patel J; Biers K; Harroun N; Doucette C; Sumner J
J Clin Virol; 2011 Mar; 50(3):201-4. PubMed ID: 21195020
[TBL] [Abstract][Full Text] [Related]
15. Detection of high-risk HPV types by the hybrid capture 2 test.
Terry G; Ho L; Londesborough P; Cuzick J; Mielzynska-Lohnas I; Lorincz A
J Med Virol; 2001 Sep; 65(1):155-62. PubMed ID: 11505458
[TBL] [Abstract][Full Text] [Related]
16. Detection and typing of human papillomaviruses by means of polymerase chain reaction and fragment length polymorphism in male genital lesions.
Grce M; Husnjak K; Skerlev M; Lipozencić J; Pavelić K
Anticancer Res; 2000; 20(3B):2097-102. PubMed ID: 10928159
[TBL] [Abstract][Full Text] [Related]
17. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.
Eder PS; Lou J; Huff J; Macioszek J
J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374
[TBL] [Abstract][Full Text] [Related]
18. Multiplex nested PCR (MNP) assay for the detection of 15 high risk genotypes of human papillomavirus.
Brestovac B; Harnett GB; Smith DW; Frost F; Shellam GR
J Clin Virol; 2005 Jun; 33(2):116-22. PubMed ID: 15911426
[TBL] [Abstract][Full Text] [Related]
19. Novel polymerase chain reaction method for detecting cutaneous human papillomavirus DNA.
Sasagawa T; Mitsuishi T
J Med Virol; 2012 Jan; 84(1):138-44. PubMed ID: 22052582
[TBL] [Abstract][Full Text] [Related]
20. High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups.
Leo E; Venturoli S; Cricca M; Musiani M; Zerbini M
J Clin Virol; 2009 Aug; 45(4):304-10. PubMed ID: 19473874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
